Lidocaïne Hcl B. Braun (Lidocaine Hydrochloride Monohydrate)

Lidocaine blocks voltage‑gated sodium channels on nerve and cardiac cell membranes, preventing the rapid influx of sodium that initiates an action potential. This stops nerve impulse transmission for local anesthesia and reduces abnormal electrical activity in the heart, helping to control arrhythmias.

The appropriate dose is determined by the prescribing clinician based on the intended route (intraosseous or intravenous), the procedure, patient weight, age, and clinical condition. Dosing guidelines are provided in the product’s prescribing information and must be followed by a qualified health professional.

Safety data for lidocaine hydrochloride in pregnancy and lactation are limited, and the product’s pregnancy category is not established. Use only if the potential benefit justifies any potential risk to the fetus or infant, and consult a healthcare professional for individualized assessment.

Submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and any required import documentation.

Lidocaine is an amide‑type local anesthetic with a rapid onset and moderate duration, making it suitable for short procedures and emergency cardiac use. Compared with ester‑type agents such as procaine, lidocaine has a lower risk of allergic reactions and a more predictable pharmacokinetic profile.

Lidocaïne Hcl B. Braun should be stored at room temperature, below 25 °C, in its original packaging. Protect the solution from moisture, direct sunlight and extreme temperatures. Do not freeze the product, and inspect the container for any signs of contamination before use.

The product is supplied as a sterile solution for intraosseous or intravenous injection. Administration is performed by a qualified healthcare professional using aseptic technique, with the dose and rate adjusted to the clinical indication and patient characteristics.

Serious risks include seizures, severe cardiac conduction disturbances (such as bradycardia or heart block), anaphylactic reactions, methemoglobinemia, and respiratory depression. Prompt recognition and supportive measures are essential if any of these events occur.

Patients with known hypersensitivity to lidocaine or other amide‑type local anesthetics, those with severe hepatic impairment, and individuals with certain pre‑existing cardiac conduction disorders should avoid this product unless a specialist determines that benefits outweigh risks.